As international mobility expands and Africa’s economic, humanitarian, and corporate footprint continues to grow, the question of how to deliver effective medical evacuation and assistance across the continent is coming under sharper focus. Standardised global medevac models have long dominated the market. Yet, as insurers, employers, non-governmental organisations (NGOs), and high-risk travellers extend their presence into more remote or politically complex regions, the suitability of those models is increasingly being tested.

Where global medevac assumptions break down

For Dr Cédric Ramaut, Chief Medical Officer at Allianz Partners France, the starting point is a structural mismatch between product design and on-the-ground reality. “Global medevac products are typically designed around assumptions about infrastructure and systems that do not consistently exist across many parts of Africa.”

He pointed first to the physical and clinical infrastructure that underpins evacuation planning. “First, aviation and medical infrastructure can be limited. Many locations lack reliable airports, paved runways, night-landing capability, or nearby advanced medical facilities. This restricts where aircraft can land and how quickly a patient can be stabilised.”

In many regions, the absence of suitable runways or night-landing facilities fundamentally changes response options, narrowing the window for safe evacuation or requiring multi-stage transfers.

Dr Ramaut then highlighted operational friction points that are often underestimated in globalised models: “Second, operational barriers add complexity. Language differences, fragmented healthcare systems, and unpredictable permitting or customs processes for medical teams, medications, and equipment can delay response times at critical moments.”

He also pointed to aviation capacity itself as a critical constraint. “Third, there is a shortage of dedicated air ambulances on the continent, particularly aircraft equipped for ICU-level transport.

As a result, response times can be significantly longer than global medevac models assume.”

Taken together, these constraints create tangible exposure for travellers and organisations. “Evacuations may be delayed, missions can become logistically impossible, and patients may remain in facilities unable to provide the required level of care. When aircraft must be deployed from outside the continent, costs escalate rapidly, often placing evacuation beyond reach,” said Dr Ramaut.

Dr Ahmed Monir, Founder of LGA Group, agreed: “Standard global medevac products are usually built for ‘stable’ systems: clear hospital rules, predictable admin, and straightforward flight routes. In a lot of Africa, it’s different. The reality is more layered: hospitals vary widely, paperwork and deposits can slow everything down, and aviation access can change fast.”

For medical risk specialists, this highlights the importance of understanding the full operating environment before travel takes place. Dr Lynn Gordon, Chief Medical Officer at Charles Taylor Assistance, told ITIJ: “The best way to ensure that risk is mitigated for individuals and organisations travelling to Africa is to look at the full picture, beyond pre-travel vaccinations and cultural challenges. This means not just making sure that the insured is fit to travel, but also that they have a clear cultural awareness and an understanding of local conditions, including extreme temperatures, adverse weather events, unsafe food and water, political instability, and a potential lack of suitable local medical facilities.

“Looking to the future, in the context of climate change, it will become increasingly important to focus on the risks of extreme heat and other weather events, such as flooding,” added Dr Gordon.

Navigating airspace, politics, and regulatory uncertainty

Beyond infrastructure, the aviation and political landscape across Africa adds another layer of complexity. Securing clearance to move an aircraft across multiple jurisdictions can be a decisive factor in patient outcomes.

Dr Monir pointed out that in Africa airspace closures, permit delays, security shifts, and politics can turn a routine mission into hours or days. “Rerouting means longer flight times, more fuel, tighter crew duty limits, and sometimes ground movement becomes the real bottleneck. From what I’ve seen, overflight permits are often the biggest delay point.”

In many regions, the absence of suitable runways or night-landing facilities ‎fundamentally changes response options

Dr Charles Crawshaw and Peter Flemmer, consultants at HAC Medical, added: “In countries such as Mozambique and Zambia, airspace may be controlled by military authorities. While maintaining strong professional relationships helps, approvals can be unpredictable, particularly at night or outside government working hours. Overflight and landing permits often depend on administrative offices being open.”

When medical urgency meets bureaucratic timelines, tensions inevitably arise. These operational constraints are further complicated by political volatility, which can rapidly reshape flight planning.

Dr Ramaut stressed how quickly conditions can change. “Political uncertainty and geographical unpredictability can compound these issues. Sudden airspace closures linked to conflicts, elections, or regime changes can immediately invalidate planned routes, forcing aircraft to reroute across longer distances or seek last-minute permissions from alternative states. In some cases, additional approvals are required specifically for medical flights, the transport of pharmaceuticals, or the entry of foreign medical crews.”

For operators on the ground, this volatility means missions must often be managed dynamically rather than according to fixed plans. Dr Monir noted an example of LGA’s experience of this in Sudan. “Success wasn’t about speed on paper, it was about running a synchronised system in real time: intelligence, ground extraction, permits, and medical decisions, all while conditions changed hour by hour,” he said.

Such unpredictability presents a challenge for assistance products designed around fixed response guarantees. In Dr Ramaut’s view, flexibility must be engineered into assistance structures from the outset. “To manage this reality, assistance products need to be designed with built-in flexibility. This includes positioning aircraft across multiple regions of the continent, maintaining alternative routing options, and integrating ground or regional air transport where direct evacuation is not immediately possible. Providers should also maintain pre-negotiated overflight permissions and established diplomatic channels with key governments to accelerate approvals when crises occur.”

Operationally, this is why providers often emphasise the importance of early activation. Dr Crawshaw and Flemmer explained: “When operators stress the urgency of early activation, it reflects these practical constraints rather than commercial pressure. The earlier a service is activated, the sooner permits, clearances, and airport arrangements can begin.”

For some organisations, the solution lies in embedding regional expertise directly into product design. Annick Breton, National Liaison Manager at Alliance International Medical Services (AIMS), commented: “From an AIMS perspective, assistance products must be built with flexibility incorporating regional aviation expertise, pre-cleared routing options, strong diplomatic and ground networks, and clear clinical contingency planning. Solutions designed around fixed timelines or single-route assumptions risk patient deterioration, operational disruption, and significant cost escalation.”

Alongside aviation and diplomatic considerations, medical coordination remains a critical part of the equation. Jane Munyua, Medical Assistance and Networking Manager at AMREF Flying Doctors, emphasised the importance of clear dialogue. “Open communication between local treating physicians and international medical directors is fundamental. Frequent in-person audits of regional hospitals help ensure that advice given to insurers or employers is grounded in practical capability rather than formal designation.”

The message across the sector is consistent: the realities of airspace management and political fluidity cannot be managed reactively. They must be anticipated and structurally accommodated within the product itself.

Choosing between local stabilisation, regional transfer, and international evacuation

In regions where healthcare capacity varies widely, deciding whether to treat locally, transfer regionally, or evacuate internationally requires critical and nuanced judgement. It carries implications not only for clinical outcomes but also for cost exposure and operational risk.

For assistance providers, the decision is rarely binary. Instead, it is typically guided by a structured clinical and logistical assessment. Dr Ramaut outlined the decision-making framework: “Providers will generally make this decision via a clinical prioritisation process where both the patient’s condition and on-the-ground logistics are evaluated. The patient’s condition, their capability for transport, and the ability of the treating facility need to be evaluated, as well as the realistic transport options available.”

In practice, this often leads to regional transfers rather than immediate repatriation. Dr Ramaut explained: “In many parts of Africa, required specialist care or equipment may not be available, meaning regional transfers to a medical centre in a neighbouring country may be required. This can often improve clinical outcomes while keeping costs and transport risks minimal.”

International evacuation therefore remains an important option, but not necessarily the default pathway. “International evacuation is typically reserved for cases where appropriate care is unavailable regionally. While it can provide access to advanced treatment, it involves higher costs, longer coordination timelines, and greater operational complexity.”

Even within this structured framework, financial considerations still surface as a factor in operational planning. As Dr Ramaut noted: “Regardless of the scenario, cost pressures can still emerge, due to issues such as limited provider competition or logistical constraints.”

For some providers, the key lies in balancing speed with clinical prudence. Breton underscored the risks of moving too quickly – or too slowly: “Premature long-haul evacuation can increase clinical risk and cost, while delayed escalation can compromise outcomes. The optimal pathway is therefore a staged, medically led approach prioritising safe stabilisation, utilising the most appropriate regional centre where possible, and reserving international evacuation for cases where definitive care cannot be delivered within the region. This balances patient safety, clinical outcomes, and responsible cost containment.”

Evacuation planning in Africa is rarely a simple choice between local treatment and international repatriation. Rather, industry experts increasingly describe a layered pathway informed by clinical need, logistical feasibility, and cost stewardship.

The decisive role of local intelligence and partnerships

For many operators, the difference between a theoretical plan and a successful mission lies in the strength of on-the-ground networks. Dr Monir emphasised that local intelligence was key in Africa. “It tells you which hospital will accept the case, who can be trusted clinically, what the real-time security picture looks like, and how to unblock admin barriers fast.” And it’s not just hospital relationships, he added: “In high-risk environments, trusted channels with the relevant authorities make a measurable difference: health regulators, civil aviation, border points, and the right government touch points.”

From a provider perspective, these relationships form the operational backbone of effective assistance. Dr Ramaut added: “They inform aviation decisions, clinical prioritisation, and security navigation. Insurers and employers should evaluate providers by requesting activity volumes, equipment lists with maintenance proof, transparent partner networks, certifications, and a local medical director in key sub-regions. Field audits and performance-based service-level agreements (SLAs) tested through simulation exercises are the strongest indicators that claimed partnerships translate into operational reality.”

Breton reinforces the centrality of granular, real-time knowledge: “Real-time knowledge of facility capability, transport logistics, regulatory pathways, and regional risk allows for faster clinical decisions, safer transfers, and stronger cost control. Insurers and employers should therefore look beyond global branding and assess proven regional networks, in-country presence, clinical governance, and a demonstrated track record of complex case management.”

Across these perspectives, credibility is closely tied to verifiable presence and tested relationships. This also shapes how insurers and assistance companies approach due diligence and preparedness before a case ever arises. “For insurers and assistance companies, proper vetting and long-term partnership are essential,” emphasised Dr Crawshaw and Flemmer.

Designing the next generation of Africa-fit assistance

As demand from corporates, NGOs and high-risk travellers grows, industry participants are increasingly looking ahead to how medical assistance models may need to evolve.

Dr Ramaut highlighted that existing frameworks cannot simply be adapted from other regions. “A medevac model designed for Africa cannot be a one-for-one replacement of Western assistance structures. It needs to be built around the realities of the continent: distance, infrastructure variability, and political complexity.

Political uncertainty and geographical unpredictability can compound these issues

“A key priority should be a distributed air ambulance network, with fixed-wing aircraft based in at least three African hubs, supported by helicopters for shorter intra-country transfers.”

Alongside aviation resources, Dr Ramaut pointed to the growing importance of real-time data and operational visibility. “An integrated intelligence platform providing real-time visibility of available medical facilities is also essential. Such a platform could validate care levels and make recommendations based on trauma centre classification in real time.”

Building such systems, he suggested, would require collaboration beyond the private assistance sector alone. “Success will depend on public-private collaboration with regional health bodies, including African Union health agencies, the Africa Centres for Disease Control and Prevention (Africa CDC), and local ministries of health.”

In this context, he references organisations such as Africa CDC as part of a broader ecosystem shaping regional health resilience.

At the same time, product architecture itself may need to become more flexible to reflect the continent’s varied operating environments. “Finally, the product must offer dynamic modular coverage, pricing, and services that adapt to accessibility, risk level, and available infrastructure across regions.”

Taken together, these elements form the basis of what Dr Ramaut sees as the next phase of assistance provision in Africa. “In short, the next generation of African medevac services will combine locally based aviation capacity, verified medical networks, and real-time intelligence to deliver solutions designed specifically for the continent rather than adapted from elsewhere.”

Breton’s forward-looking view aligns with many of these themes and highlights how product design may evolve in practice. “This would mean integrated local reliable networks, real-time intelligence, scalable aviation solutions, and staged evacuation pathways that prioritise safe stabilisation, appropriate regional care, and international transfer only when clinically necessary. It will also embed transparent cost governance, strong duty-of-care support for corporates and NGOs, and proactive risk planning, delivering safer outcomes, faster response, and sustainable cost control across diverse African environments.”

A continent-specific model

Across their responses, experts converged on a shared conclusion: Africa cannot be served effectively by simply exporting global assistance templates. Infrastructure variability, airspace regulation, political shifts, and uneven healthcare capacity demand products engineered around flexibility, intelligence, and genuine local partnership. As Munyua told ITIJ, an “Africa-fit” product cannot merely replicate models developed elsewhere; it must recognise the continent’s diversity of culture, infrastructure, regulation, and clinical capacity – and accept that predictability cannot always be assumed.